{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:22:45Z","timestamp":1767846165696,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK07011"],"award-info":[{"award-number":["DK07011"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hellenic Journal of Cardiology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.hjc.2023.01.006","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T12:38:56Z","timestamp":1675427936000},"page":"75-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Newer alternatives for resistant hypertension: Beyond 2022 paradigms"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3262-792X","authenticated-orcid":false,"given":"Luke J.","family":"Laffin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5740-9670","authenticated-orcid":false,"given":"Alexandros","family":"Briasoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George L.","family":"Bakris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10285","key":"10.1016\/j.hjc.2023.01.006_bib1","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","article-title":"Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis","volume":"397","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.hjc.2023.01.006_bib2","first-page":"e13","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"issue":"33","key":"10.1016\/j.hjc.2023.01.006_bib3","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.hjc.2023.01.006_bib4","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jamacardio.2017.1421","article-title":"Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis","volume":"2","author":"Bundy","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"8","key":"10.1016\/j.hjc.2023.01.006_bib5","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.hjc.2023.01.006_bib6","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jama.2020.14545","article-title":"Trends in Blood Pressure Control Among US Adults With Hypertension","volume":"324","author":"Muntner","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.hjc.2023.01.006_bib7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/CIRCULATIONAHA.121.057075","article-title":"Rise in Blood Pressure Observed Among US Adults During the COVID-19 Pandemic","volume":"145","author":"Laffin","year":"2022","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.hjc.2023.01.006_bib8","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1016\/j.jacc.2019.03.507","article-title":"ACC\/AHA Versus ESC\/ESH on Hypertension Guidelines: JACC Guideline Comparison","volume":"73","author":"Bakris","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"26","key":"10.1016\/j.hjc.2023.01.006_bib9","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1056\/NEJMoa2212270","article-title":"Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events","volume":"387","author":"Ishani","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.hjc.2023.01.006_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.hjc.2023.01.006_bib11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.7326\/M20-4873","article-title":"Testing for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among U.S. Veterans : A Retrospective Cohort Study","volume":"174","author":"Cohen","year":"2021","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.hjc.2023.01.006_bib12","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1161\/HYPERTENSIONAHA.119.14504","article-title":"Randomized Dose-Response Study of the New Dual Endothelin Receptor Antagonist Aprocitentan in Hypertension","volume":"75","author":"Verweij","year":"2020","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.hjc.2023.01.006_bib13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/HYPERTENSIONAHA.121.17073","article-title":"Effect of KBP-5074 on Blood Pressure in Advanced Chronic Kidney Disease: Results of the BLOCK-CKD Study","volume":"78","author":"Bakris","year":"2021","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.hjc.2023.01.006_bib14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCULATIONAHA.119.040070","article-title":"Efficacy and Safety of Firibastat, A First-in-Class Brain Aminopeptidase A Inhibitor, in Hypertensive Overweight Patients of Multiple Ethnic Origins","volume":"140","author":"Ferdinand","year":"2019","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hjc.2023.01.006_bib15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jacbts.2021.04.004","article-title":"Antisense Inhibition of Angiotensinogen With IONIS-AGT-LRx: Results of Phase 1 and Phase 2 Studies","volume":"6","author":"Morgan","year":"2021","journal-title":"JACC Basic Transl Sci"},{"issue":"5","key":"10.1016\/j.hjc.2023.01.006_bib16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"},{"issue":"10333","key":"10.1016\/j.hjc.2023.01.006_bib17","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/S0140-6736(22)00455-X","article-title":"Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial","volume":"399","author":"Mahfoud","year":"2022","journal-title":"Lancet"},{"issue":"10137","key":"10.1016\/j.hjc.2023.01.006_bib18","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/S0140-6736(18)31082-1","article-title":"RADIANCE-HTN Investigators. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial","volume":"391","author":"Azizi","year":"2018","journal-title":"Lancet"},{"issue":"10293","key":"10.1016\/j.hjc.2023.01.006_bib19","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/S0140-6736(21)00788-1","article-title":"RADIANCE-HTN investigators. Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial","volume":"397","author":"Azizi","year":"2021","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.hjc.2023.01.006_bib20","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1001\/jama.2020.20356","article-title":"A National Commitment to Improve the Care of Patients With Hypertension in the US","volume":"324","author":"Adams","year":"2020","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.hjc.2023.01.006_bib21","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1056\/NEJMoa2105675","article-title":"Effect of Salt Substitution on Cardiovascular Events and Death","volume":"385","author":"Neal","year":"2021","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.hjc.2023.01.006_bib22","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1717250","article-title":"A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops","volume":"378","author":"Victor","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hjc.2023.01.006_bib23","unstructured":"American Heart Association CfHTI. Self-Measured Blood Pressure Digital Health Platform Provider Landscape 2022. Available from: https:\/\/ahahealthtech.org\/wp-content\/uploads\/2022\/02\/SMBP_Digital-Health-Platform-Provider-Landscape_FINAL-02-10-2022_Total-Document.pdf."}],"container-title":["Hellenic Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966623000222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966623000222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:15:17Z","timestamp":1761099317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1109966623000222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":23,"alternative-id":["S1109966623000222"],"URL":"https:\/\/doi.org\/10.1016\/j.hjc.2023.01.006","relation":{},"ISSN":["1109-9666"],"issn-type":[{"value":"1109-9666","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Newer alternatives for resistant hypertension: Beyond 2022 paradigms","name":"articletitle","label":"Article Title"},{"value":"Hellenic Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hjc.2023.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Hellenic Society of Cardiology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}